This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated NDP Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NDP WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~15 kDa | |
| Gel | 15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Cleaved + Disulfide-linked | |
| Caveat | Reducing-condition controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A01045 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Jurkat cell lysate (catalog A01045) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A01045 · (A) 1 and (B) 2 μg/mL (catalog A01045) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
Norrin’s full-length precursor is predicted at 15 kDa; secretion, signal-peptide cleavage, and disulfide-linked dimerization could affect the blot, but no migration is empirically established.
| Band near 15 kDa | Consistent with the predicted full-length precursor; confirm identity with controls |
| Band below 15 kDa | Could reflect removal of the 1–24 signal peptide |
| Band near twice the monomer mass under nonreducing conditions | Consistent with the disulfide-linked homodimer |
| Little or no band in whole-cell lysate | Norrin is secreted |
| Predicted full-length precursor mass | Provides a 15 kDa reference, not a measured band position |
| Signal peptide at residues 1–24 | Its cleavage yields a mature protein smaller than the precursor |
| Disulfide-linked homodimer | May yield a band near twice the monomer mass under nonreducing conditions |
| Reduction of interchain disulfides | Can shift a dimer band to monomer-sized material |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Norrin is secreted | Check conditioned medium and use an appropriate positive control |
| Band higher than expected | Disulfide-linked homodimer may persist | Compare reducing and nonreducing samples |
| Band lower than expected | Signal-peptide cleavage may remove residues 1–24 | Compare precursor and secreted samples with an identity control |
| Multiple bands | Precursor, mature protein, or incompletely reduced dimer may coexist | Compare sample fractions and reducing conditions, then verify identity |
| Weak or no signal | Secreted Norrin may be scarce in the tested fraction | Check conditioned medium and verify antibody performance with a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for NDP, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A01045 is a human-reactive anti-NDP antibody with a Western blot image using Jurkat cell lysate at 1 and 2 μg/mL. The supplied evidence shows this sample and these conditions only; broader validation is not documented.
Which to pick: A01045 is the only listed NDP antibody. It has a Western blot image from Jurkat cell lysate, so use that sample and the reported 1–2 μg/mL concentrations as a starting point.